Literature DB >> 33945838

Investigation of two cases of Mycobacterium chelonae infection in haemato-oncology patients using whole-genome sequencing and a potential link to the hospital water supply.

T Inkster1, C Peters2, A L Seagar3, M T G Holden4, I F Laurenson3.   

Abstract

BACKGROUND: Haemato-oncology patients are at increased risk of infection from atypical mycobacteria such as Mycobacterium chelonae which are commonly found in both domestic and hospital water systems. AIMS: To describe the investigation and control measures following two patient cases of M. chelonae and positive water samples in the study hospital.
METHODS: Water testing was undertaken from outlets, storage tanks and mains supply. Whole-genome sequencing (WGS) was used to compare patient and positive water samples. The subsequent infection control measures implemented are described.
FINDINGS: The WGS results showed two main populations of M. chelonae within the group of sampled isolates. The results showed that the patient strains were unrelated to each other, but that the isolate from one patient was closely related to environmental samples from water outlets, supporting nosocomial acquisition.
CONCLUSIONS: WGS was used to investigate two patient cases of M. chelonae and positive water samples from a hospital water supply. Relevant control measures and the potential for chemical dosing of water systems to enhance proliferation of atypical mycobacteria are discussed. Crown
Copyright © 2021. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immunosuppression; Mycobacterium chelonae; Water; Whole-genome sequencing

Year:  2021        PMID: 33945838     DOI: 10.1016/j.jhin.2021.04.028

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  1 in total

1.  Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.

Authors:  Jessica S Little; Rebekah M Dedrick; Krista G Freeman; Madison Cristinziano; Bailey E Smith; Constance A Benson; Tulip A Jhaveri; Lindsey R Baden; Daniel A Solomon; Graham F Hatfull
Journal:  Nat Commun       Date:  2022-05-03       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.